101 related articles for article (PubMed ID: 6531759)
1. Improved assay conditions for automated antithrombin III determinations with the chromogenic substrate S-2238.
van Voorthuizen H; Kluft C
Thromb Haemost; 1984 Dec; 52(3):350-3. PubMed ID: 6531759
[TBL] [Abstract][Full Text] [Related]
2. Improved assay of antithrombin-III. Effects of certain additives on thrombin and on chromogenic peptide substrates.
Gram J; Jespersen J
Clin Chem; 1985 Oct; 31(10):1683-8. PubMed ID: 4042332
[TBL] [Abstract][Full Text] [Related]
3. Polyethylene glycol can be validly omitted from chromogenic peptide substrate assay for antithrombin III.
Kolde HJ
Clin Chem; 1986 Aug; 32(8):1554-6. PubMed ID: 3731451
[TBL] [Abstract][Full Text] [Related]
4. Fully automated antithrombin-III assays by synthetic substrate on the Multistat III.
Bick RL; Wheeler A
Am J Clin Pathol; 1987 Aug; 88(2):192-7. PubMed ID: 3618551
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
[No Abstract] [Full Text] [Related]
6. [Assay of antithrombin III activity using chromogenic substrate (author's transl)].
Koresawa S; Matsuda N; Ueda S
Rinsho Byori; 1982 Jan; 30(1):54-8. PubMed ID: 7087231
[No Abstract] [Full Text] [Related]
7. Application of several chromogenic substrate assays to automated instrumentation for coagulation analysis.
Bartl K; Becker U; Lill H
Semin Thromb Hemost; 1983 Oct; 9(4):301-8. PubMed ID: 6658461
[No Abstract] [Full Text] [Related]
8. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
9. Chromogenic peptide substrate assays in patients with multiple trauma.
Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
[TBL] [Abstract][Full Text] [Related]
10. [Changes in antithrombin III values during and after extracorporeal circulation in heart surgery, measured on the day of operation using a chromogenic substrate and a laser nephelometer].
Hopmeier P; Heuss F; Fischer M
Wien Klin Wochenschr; 1984 Dec; 96(24):881-4. PubMed ID: 6528618
[TBL] [Abstract][Full Text] [Related]
11. [Significance of the amidolytic method in the typing of congenital antithrombin III deficiency].
Losonczy H; Nagy I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):184-8. PubMed ID: 6177603
[No Abstract] [Full Text] [Related]
12. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
Frantzen Handeland G; Abildgaard U; Aasen AO
Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
[TBL] [Abstract][Full Text] [Related]
13. [Antithrombin III assay using a chromogenic substrate in newborns].
De Mattia D; Montagna O; Marvulli E
Boll Soc Ital Biol Sper; 1979 Apr; 55(8):746-50. PubMed ID: 554643
[TBL] [Abstract][Full Text] [Related]
14. Methodological considerations on antithrombin determination.
Abildgaard U
Acta Chir Scand Suppl; 1982; 509():97-9. PubMed ID: 6962626
[No Abstract] [Full Text] [Related]
15. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
Asai K; Asai M
Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
[TBL] [Abstract][Full Text] [Related]
16. Measurement of antithrombin III in normal and pathologic states using chromogenic substrate S-2238. Comparison with immunoelectrophoretic and factor Xa inhibition assays.
Goodnight SH; Schaeffer JL; Sheth K
Am J Clin Pathol; 1980 May; 73(5):639-47. PubMed ID: 7377131
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
Asai K; Takagi A; Otsubo M
Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
[No Abstract] [Full Text] [Related]
18. Functional assay of plasma antithrombin using polyethylene glycol (PEG) defibrinated plasma.
Li A; Taylor FB; Chang AK; Peer GT; Dong F; Hinshaw LB
Thromb Res; 1995 Aug; 79(4):395-403. PubMed ID: 7482443
[TBL] [Abstract][Full Text] [Related]
19. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
Carmignoto F; Schivo P; Zotti S; Ceriotti G
Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
[TBL] [Abstract][Full Text] [Related]
20. Detection of plasma endotoxin with a limulus amoebocyte lysate (LAL)-chromogenic substrate assay.
Stemberger A; Strasser F; von Hundelshausen Bv; Tempel G; Blümel G
Acta Chir Scand Suppl; 1982; 509():49-53. PubMed ID: 6962619
[No Abstract] [Full Text] [Related]
[Next] [New Search]
